CVS Health has completed its acquisition of Oak Street Health, as announced by the company this week.
In February, an all-cash transaction valued at approximately $10.6 billion was announced for Oak Street Health, a primary care company focused on older adults. The company utilizes a scalable care model and technology platform.
CVS Health utilized a $5 billion term loan agreement and available resources to finance the transaction. The company has expressed its dedication to preserving its present credit ratings.
Oak Street Health will remain a primary care provider for multiple payers while being part of CVS Health.
Read more: CVS Expects To Close Oak Street Health After Passing Antitrust Hurdles
The organizations said the acquisition would benefit patients’ long-term health by reducing care costs and improving outcomes, particularly for those in underserved communities. More than 50% of Oak Street Health’s patients have a housing, food or isolation risk factor, they said.
Oak Street Health employs about 600 primary care providers and has 169 medical centers across 21 states. Its signature technology solution is Canopy, which is integrated with the company’s operations and utilized when determining the appropriate type and level of care for each patient.
Featured News
Judge Appoints Law Firms to Lead Consumer Antitrust Litigation Against Apple
Dec 22, 2024 by
CPI
Epic Health Systems Seeks Dismissal of Antitrust Suit Filed by Particle Health
Dec 22, 2024 by
CPI
Qualcomm Secures Partial Victory in Licensing Dispute with Arm, Jury Splits on Key Issues
Dec 22, 2024 by
CPI
Google Proposes Revised Revenue-Sharing Limits Amid Antitrust Battle
Dec 22, 2024 by
CPI
Japan’s Antitrust Authority Expected to Sanction Google Over Monopoly Practices
Dec 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand